Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
0.9700
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Silence Therapeutics Revenue
In the year 2024, Silence Therapeutics had annual revenue of $43.26M with 36.71% growth. Silence Therapeutics had revenue of $25.55M in the quarter ending December 31, 2024, with 1,180.58% growth.
Revenue
43.26M
Revenue Growth
+36.71%
P/S Ratio
6.07
Revenue / Employee
238.80K
Employees
116
Market Cap
168.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 43.26M | 11.62M | 36.71% |
Dec 31, 2023 | 31.64M | 9.99M | 46.12% |
Dec 31, 2022 | 21.66M | 4.84M | 28.82% |
Dec 31, 2021 | 16.81M | 9.33M | 124.73% |
Dec 31, 2020 | 7.48M | 7.16M | 2,214.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics News
- 1 day ago - Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 3 days ago - Silence Therapeutics Welcomes Tim McInerney to Board of Directors - Business Wire
- 2 months ago - Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference - Business Wire
- 2 months ago - Silence Therapeutics plc (SLN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Silence Therapeutics plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Silence Therapeutics PLC (SLNCF) Reports Full Year 2024 Financial Results with Strong Cash ... - GuruFocus
- 2 months ago - Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Redmile Group, LLC Acquires Significant Stake in Silence Therapeutics PLC - GuruFocus